Congress
$1,001–$15,000
Traded Feb 4 · disclosed 34 days laterDependent child
2 different filers disclosed LH within 90 days.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Feb 10, 2026 · Filed Feb 12, 2026
Labcorp's Operations sold $25K of Labcorp shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$25,188
Shares × reported transaction price
105 days after results of Oct 28, 2025, 7 days before results of Feb 17, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $284.50 on Feb 10, 2026, within 3% of its 52-week high, after a 12% rise over the previous 30 trading days
52-week range $212.22 (Apr 21, 2025) to $290.93 (Oct 20, 2025), 92% of the way up, from 251 adjusted closes. 30 trading days earlier: $253.89 on Dec 26, 2025. Describes the past only, not a forecast
RSI 70, 8% above its 200-day average, 8% above its 50-day average, 2% below the 52-week high, 20-day volatility 22% a year, against the S&P 500: +13 points over 1 month, +9 points over 3 months, −3 points over 6 months
From the adjusted closes up to Feb 10, 2026. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | 0.0% | +1.1% | −1.1% |
| 30 days | −5.6% | −1.9% | −3.7% |
| 90 days | −10.1% | +9.7% | −19.9% |
| 180 days | +14.4% | +13.3% | +1.1% |
Past results only. Not a forecast.
Congress
Traded Feb 4 · disclosed 34 days laterDependent child
2 different filers disclosed LH within 90 days.
Congress
Traded Feb 11 · disclosed 27 days laterDependent child
2 different filers disclosed LH within 90 days.
Insider selling
Their largest sale since 2018Traded Mar 3 · filed 2 days laterNot reported under a pre-arranged trading plan
The CEO of Labcorp sold $2.44M of Labcorp shares. The filing does not indicate a pre-arranged trading plan.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 4 days earlier (Feb 6, 2026). The first one after it: reported its results, 7 days later (Feb 17, 2026).